Telemedicine diabetes consultations are cost-effective, and efects on essential diabetes treatment parameters are similar to conventional treatment: 7-year results from the Svendborg telemedicine diabetes project

Journal of Diabetes Science and Technology

Volumn 7, Issue 3, 2013, Pages 587-595

  Levin, Klaus ^a   Madsen, Jette R ^a   Petersen, Inge ^b   Wanscher, Christina E ^c   Hangaard, Joergen ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c Health Innovation Center   (Denmark)

Author keywords

Cost effectiveness; Diabetes; Telemedicine; Videoconferencing

Indexed keywords

CREATININE; GLUCAGON LIKE PEPTIDE 1; HEMOGLOBIN A1C; LIPID; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; AUDIOVISUAL AID; BLOOD PRESSURE; BODY MASS; CLINICAL NURSE SPECIALIST; COMPARATIVE STUDY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; CREATININE BLOOD LEVEL; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE DURATION; DISEASE REGISTRY; ELECTRONIC MEDICAL RECORD; FOLLOW UP; GLYCEMIC CONTROL; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; RETROSPECTIVE STUDY; TELECONSULTATION; BLOOD; COST BENEFIT ANALYSIS; DENMARK; ECONOMICS; FEMALE; MALE; MIDDLE AGED; PROCEDURES; TELEMEDICINE; ARTICLE; METHODOLOGY;

AGED; COST-BENEFIT ANALYSIS; DENMARK; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; REMOTE CONSULTATION; RETROSPECTIVE STUDIES; TELEMEDICINE;

EID: 84892375350     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681300700302     Document Type: Conference Paper

References (23)

1. International Diabetes Federation. IDF diabetes atlas. 5th ed. Brussels: International Diabetes Federation; 2011. http://www.idf.org/diabetesatlas.
2. Patterson CC, Gyürüs E, Rosenbauer J, Cinek O, Neu A, Schober E, Parslow RC, Joner G, Svensson J, Castell C, Bingley PJ, Schoenle E, Jarosz-Chobot P, Urbonaité B, Rothe U, Krzisnik C, Ionescu-Tirgoviste C, Weets I, Kocova M, Stipancic G, Samardzic M, de Beaufort CE, Green A, Dahlquist GG, Soltész G. Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia. 2012;55(8):2142-7.
3. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus - present and future perspectives. Nat Rev Endocrinol. 2011;8(4):228-36.
4. Klonof DC. Using telemedicine to improve outcomes in diabetes - an emerging technology. J Diabetes Sci Technol. 2009;3(4):624-8.
5. Bellazzi R. Telemedicine and diabetes management: current challenges and future research directions. J Diabetes Sci Technol. 2008;2(1):98-104.
6. Verhoeven F, Tanja-Dijkstra K, Nijland N, Eysenbach G, van Gemert-Pijnen L. Asynchronous and synchronous teleconsultation for diabetes care: a systematic literature review. J Diabetes Sci Technol. 2010;4(3):666-84.
7. Health Optimum. Knowledge base home. http://kb.healthoptimum.info.
8. Dansk Voksen Diabetes Database (DVDD). National årsrapport 2011. Version 1.4. https://www.sundhed.dk/content/cms/88/4688-dvdd-kommenteret- aarsrapport.pdf.
9. Bassett B, Hangaard J, Hansen C, Hendriksen JE, Wagner H. Diabetesbehandling - den fynske model. Månedsskr Prakt Lægegern. 2006;84:33-46.
10. Danmarks Statistik. http://www.statistikbanken.dk/INDKP1.
11. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA. 2002;287(19):2563-9.
12. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577-89.
13. Dluhy RG, McMahon GT. Intensive glycemic control in the ACCORD and ADVANCE trials. N Engl J Med. 2008;358(24):2630-3. (Pubitemid 351831365)
14. Polisena J, Tran K, Cimon K, Hutton B, Mcgill S, Palmer K. Home telehealth for diabetes management: a systematic review and meta-analysis. Diabetes Obes Metab. 2009;11(10):913-30.
15. Friedman CP, Wyatt JC. Evaluation methods in biomedical informatics. 2nd ed. New York: Springer; 2006.
16. Shea S, Weinstock RS, Teresi JA, Palmas W, Starren J, Cimino JJ, Lai AM, Field L, Morin PC, Goland R, Izquierdo RE, Ebner S, Silver S, Petkova E, Kong J, Eimicke JP; IDEATel Consortium. A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus: 5 year results of the IDEATel study. J Am Med Inform Assoc. 2009;16(4):446-56.
17. Steventon A, Bardsley M, Billings J, Dixon J, Doll H, Hirani S, Cartwright M, Rixon L, Knapp M, Henderson C, Rogers A, Fitzpatrick R, Hendy J, Newman S; Whole System Demonstrator Evaluation Team. Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial. BMJ. 2012;344:e3874.
18. Paré G, Jaana M, Sicotte C. Systematic review of home telemonitoring for chronic diseases: the evidence base. J Am Med Inform Assoc. 2007;14(3):269-77. (Pubitemid 46646987)
19. Palmas W, Shea S, Starren J, Teresi JA, Ganz ML, Burton TM, Pashos CL, Blustein J, Field L, Morin PC, Izquierdo RE, Silver S, Eimicke JP, Lantigua RA, Weinstock RS; IDEATel Consortium. Medicare payments, healthcare service use, and telemedicine implementation costs in a randomized trial comparing telemedicine case management with usual care in medically underserved participants with diabetes mellitus (IDEATel). J Am Med Inform Assoc. 2010;17(2):196-202.
20. Mason JM, Young RJ, New JP, Gibson JM, Long AF, Gambling T, Friede T. Economic analysis of a telemedicine intervention to improve glycemic control in patients with diabetes mellitus: illustration of a novel analytic method. Dis Manage Health Outcomes. 2006;14(6):377-85. (Pubitemid 46121356)
21. Bergmo TS. Can economic evaluation in telemedicine be trusted? A systematic review of the literature. Cost Eff Resour Alloc. 2009;7:18.
22. Charpentier G, Benhamou PY, Dardari D, Clergeot A, Franc S, Schaepelynck-Belicar P, Catargi B, Melki V, Chaillous L, Farret A, Bosson JL, Penfornis A; TeleDiab Study Group. The diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study). Diabetes Care. 2011;34(3):533-9.
23. Abelsen B, Gaski M, Pedersen EH, Skipperud M. Is decentralisation of specialised healthcare beneficial in social and financial terms? Tidsskr Nor Laegeforen. 2004;124(9):1256-9. (Pubitemid 40331803)